Catalyst President Nancy Bradish Myers and fellow Big Data panelists took time out from the DIA annual meeting to talk about how Big Data is transforming drug development and health care delivery.
As Brad Hirsch, Flatiron Health Senior Medical Director, says: “This idea of a rapid learning system that we’ve been talking about for a decade is starting to come to fruition. We’re going to really start being able to use the data we’re aggregating from clinical trials, from clinical practice, from genomics, from claims data to really start understanding how to improve the care we’re delivering and constantly iterate on it.”
Mike Doherty, Roche Chief Innovation Strategy Officer, notes that Roche is working on a number of different areas of innovation involving Big Data, including cloud-based solutions for sharing data with regulators, machine learning in pharmacovigilance, systems biology, EHRs and decentralized clinical trials.
As Ms. Myers points out, “I think the industry is going to need to work collaboratively with FDA and others to really understand the quality of the data.”